Cargando…
Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B(2)
BACKGROUND: Thromboxane is a key clinical risk endpoint of smoking-induced inflammation which has been associated in the pathogenesis of cardiovascular disease. The goal of this review is to quantify the effect of smoking and smoking cessation on one of its urinary metabolites, 11-dehydrothromboxane...
Autores principales: | van der Plas, Angela, Pouly, Sandrine, de La Bourdonnaye, Guillaume, Ng, Wee Teck, Baker, Gizelle, Lüdicke, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977536/ https://www.ncbi.nlm.nih.gov/pubmed/29854626 http://dx.doi.org/10.1016/j.toxrep.2018.04.005 |
Ejemplares similares
-
Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
por: van der Plas, Angela, et al.
Publicado: (2018) -
Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels
por: van der Plas, Angela, et al.
Publicado: (2023) -
Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days
por: Haziza, Christelle, et al.
Publicado: (2016) -
Smoking and apolipoprotein levels: A meta-analysis of published data
por: Kauss, Alba Romero, et al.
Publicado: (2022) -
Urinary 11‐Dehydro‐Thromboxane B(2) as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
por: Szczeklik, Wojciech, et al.
Publicado: (2016)